Noncoding RNAs in drug-resistant pancreatic cancer: A review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Noncoding RNAs in drug-resistant pancreatic cancer: A review

Published:2020-11 Issue: Volume:131 Page:110768
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Lin Zhengjun,Lu Shiyao,Xie Xubin,Yi Xuyang,Huang He

Funder

National Natural Science Foundation of China

Hunan Province Natural Sciences Foundations of China

Xinjiang Uygur Autonomous Region "Tianshan Youth Program" of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference176 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

3. Cancer statistics, 2015;Siegel;CA Cancer J. Clin.,2015

4. Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies;Teague;Ther. Adv. Med. Oncol.,2015

5. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine;Yang;Mol. Cancer,2015

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of cationic pH-sensitive liposomes with Gemcitabine loading and Fucoidan-coating against pancreatic cancer cells;Journal of Drug Delivery Science and Technology;2024-10

2. Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications;Molecular Cancer;2024-09-07

3. Atypical phosphatase DUSP11 inhibition promotes nc886 expression and potentiates gemcitabine-mediated cell death through NF-kB modulation;Cancer Gene Therapy;2024-07-24

4. Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells;Cancers;2024-04-29

5. Long noncoding RNAs in pancreas cancer: from biomarkers to therapeutic targets;Turkish Journal of Medical Sciences;2023-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3